IRIS
FICORELLA, Corrado
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.420
EU - Europa 6.920
AS - Asia 6.680
SA - Sud America 896
Continente sconosciuto - Info sul continente non disponibili 297
AF - Africa 107
OC - Oceania 14
Totale 28.334
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.197
SG - Singapore 2.863
IE - Irlanda 1.514
CN - Cina 1.437
RU - Federazione Russa 1.322
IT - Italia 1.116
BR - Brasile 755
TR - Turchia 748
DE - Germania 702
HK - Hong Kong 637
VN - Vietnam 552
SE - Svezia 548
UA - Ucraina 439
GB - Regno Unito 423
FR - Francia 257
FI - Finlandia 236
CA - Canada 119
IN - India 99
CZ - Repubblica Ceca 79
BD - Bangladesh 65
PL - Polonia 61
JP - Giappone 58
NL - Olanda 57
MX - Messico 47
BE - Belgio 42
AR - Argentina 40
IQ - Iraq 35
ZA - Sudafrica 35
ES - Italia 32
EC - Ecuador 23
MA - Marocco 23
ID - Indonesia 20
CO - Colombia 19
JM - Giamaica 17
UZ - Uzbekistan 17
VE - Venezuela 17
AT - Austria 15
PY - Paraguay 14
AU - Australia 13
CL - Cile 13
AE - Emirati Arabi Uniti 12
MY - Malesia 12
RO - Romania 12
HN - Honduras 11
IL - Israele 11
KR - Corea 11
PK - Pakistan 11
JO - Giordania 10
KE - Kenya 10
PT - Portogallo 10
SA - Arabia Saudita 10
TN - Tunisia 10
TH - Thailandia 9
AZ - Azerbaigian 8
BG - Bulgaria 8
EU - Europa 8
NP - Nepal 8
PH - Filippine 8
EG - Egitto 7
LT - Lituania 7
RS - Serbia 7
DZ - Algeria 6
EE - Estonia 6
PE - Perù 6
TT - Trinidad e Tobago 6
BO - Bolivia 5
CH - Svizzera 4
CR - Costa Rica 4
KH - Cambogia 4
PR - Porto Rico 4
TW - Taiwan 4
AL - Albania 3
AO - Angola 3
BN - Brunei Darussalam 3
CG - Congo 3
DO - Repubblica Dominicana 3
HR - Croazia 3
IR - Iran 3
KZ - Kazakistan 3
LB - Libano 3
LY - Libia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
DM - Dominica 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
KG - Kirghizistan 2
MD - Moldavia 2
MN - Mongolia 2
NO - Norvegia 2
OM - Oman 2
PS - Palestinian Territory 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BF - Burkina Faso 1
BS - Bahamas 1
Totale 28.019
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.682
Chandler 1.617
Singapore 1.530
Dublin 1.514
San Jose 1.222
Dallas 1.159
Ashburn 828
Hong Kong 624
Santa Clara 573
Boardman 532
Council Bluffs 424
Izmir 360
The Dalles 344
New York 298
Wilmington 293
Nanjing 280
Lawrence 240
Princeton 240
Ann Arbor 235
San Mateo 224
Beijing 217
Moscow 216
Ho Chi Minh City 179
Los Angeles 164
Milan 153
Hanoi 130
Munich 120
Lauterbourg 116
Rome 99
Nanchang 98
Seattle 88
São Paulo 80
Bremen 77
Brno 75
Columbus 70
Helsinki 68
Shenyang 64
Des Moines 59
Verona 58
Woodbridge 58
Dearborn 55
Tianjin 55
Tokyo 55
Frankfurt am Main 50
Warsaw 50
Hefei 49
L'aquila 49
Hebei 44
Naples 44
Amsterdam 43
Orem 42
Brussels 41
London 38
Kunming 36
Brooklyn 35
Dong Ket 34
Chicago 33
Jinan 33
Montreal 33
Philadelphia 33
Stockholm 33
Atlanta 32
San Francisco 31
Jiaxing 30
Norwalk 30
Hangzhou 28
Phoenix 28
Zhengzhou 28
Toronto 27
Denver 26
Falkenstein 26
Johannesburg 25
Guangzhou 23
Houston 23
Florence 22
Shanghai 22
Boston 21
Changsha 21
Da Nang 21
Pune 21
Chennai 20
Mountain View 20
Rio de Janeiro 20
Brasília 19
Ningbo 18
Poplar 18
Aquila 17
Haiphong 17
Turin 17
Belo Horizonte 16
Casablanca 16
Buffalo 15
Falls Church 15
Tashkent 15
Lappeenranta 14
Auburn Hills 13
Bari 13
Bologna 13
Guayaquil 13
Manchester 13
Totale 18.100
Salva come PNG Salva come JPEG
Nome #
Breast cancer and psychological resilience among young women 296
The supportive care task force at the University of L'Aquila: 2-years experience 218
The prevalent KRAS exon 2 c.35 G > A mutation in metastatic colorectal cancer patients: a biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens? 202
Emotional Impact of Breast Cancer Treatment: cross-sectional study on level of anxiety, anger, psychological distress and depression in 2-years perspective 190
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 189
Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines 181
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 176
Does pain intensity predict a poor opioid response in cancer patients? 175
Psychological impact of clinical treatment after breast cancer diagnosis in younger patients (38–50 age range): An explorative 3-year observational study 173
Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study 172
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 170
P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer 169
Bone targeted therapy for preventing skeletal-related events in metastatic breast cancer 169
Concurrent RAS and RAS/BRAF V600E variants in colorectal cancer: more frequent than expected? 168
Dose-finding study of oxaliplatin associated to capecitabine based preoperative chemoradiotherapy in locally advanced rectal cancer 164
Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer 163
"Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer 161
New schedule of bevacizumab/paclitaxel as first-line therapy for metastatic HER2-negative breast cancer in a real-life setting 159
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 158
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 158
Hypoxia sustains glioblastoma radioresistance through ERKs/DNA-PKcs/HIF-1α functional interplay 156
Evaluating the role of FAMIly history of cancer and diagnosis of multiple neoplasms in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: the multicenter FAMI-L1 study 156
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status. 155
Efficacy and safety of deep, continuous palliative sedation at home: A retrospective, single-institution study 155
Tapentadol in cancer pain management: a prospective open-label study 154
Oncology together for L'Aquila: early resumption of integrated oncological activities after the earthquake 153
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index 152
Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study 151
Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancer 151
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 151
Differential prognosis of metastatic colorectal cancer patients post-progression to first-line triplet chemotherapy plus bevacizumab, Fir-B/FOx, according to seconde-line treatment and KRAS genotype 148
Predictive Features of Resilience in Early Breast Cancer Young Patients: experience in Real Life 148
two simulteneous and very uncommom pi3kca mutations in a liver metastasis from colorectal cancer patient with aggressive and resistant disease 148
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients 148
Expression of pro-angiogenic factors as potential biomarkers in experimental models of colon cancer 148
Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience 147
Pain evaluation and management: a survey of Italian radiotherapists 147
Multicentric retrospective analysis of platinum-pemetrexed regimens as first-line therapy in non-squamous non-small cell lung cancer patients: A "snapshot" from clinical practice 147
Haloperidol for the treatment of opioid addiction in advanced cancer patients: a case series 147
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement? 145
Dose-dense nonpegylated liposomal doxorubicin and docetaxel combination in breast cancer: Dose-finding study 143
The possible different roles of denosumab in prevention and cure breast cancer bone metastases: A ‘hypothesis-generator’ study from clinical practice 143
Evaluation of second-line anti-VEGF after first-line anti-EGFR based therapy in RAS wild-type metastatic colorectal cancer: The multicenter “SLAVE” study 143
Circulating micrornas as prognostic and therapeutic biomarkers in breast cancer molecular subtypes 142
Single-institution study of correlations between skeletal muscle mass, its density, and clinical outcomes in non-small cell lung cancer patients treated with first-line chemotherapy 141
Bioclinical parameters driving decision-making of subsequent lines of treatment in metastatic castration-resistant prostate cancer 140
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer 140
Integrating oncology and palliative home care in Italy: the experience of the "L'Aquila per la Vita" Home Care Unit 137
Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barré Syndrome 137
Efficacy of pregabalin in the management of cetuximab-related itch 136
Switching from Transdermal Drugs: An Observational "N of 1" Study of Fentanyl and Buprenorphine 136
Gabapentin in the treatment of severe sweating experienced by advanced cancer patients 136
Knowledge and Attitudes of Young Italian Medical Oncologists Toward the Approach and Treatment of Pain: No Changes, Despite the Law 136
Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events 136
A case of segmental hepatic necrosis complicating oxaliplatin and capecitabine chemotherapy: A case report and review of the literature 136
Multimodality treatment in metastatic gastric cancer: From past to next future 136
Evaluation of prognostic factors for survival in transverse colon cancer 136
Assessment and treatment of symptoms among italian medical oncologists 135
What Is Known about Theragnostic Strategies in Colorectal Cancer 135
Low morphine doses in opioid-naive cancer patients with pain 134
Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line 134
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: When overweight becomes favorable 134
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors 134
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 133
Poker association of weekly alternating 5-fluorouracil, irinotecan,bevacizumab and oxaliplatin (FIrB/FOx) in first line treatment of metastatic colorectal cancer: a phase II study 132
Meccanismo d’azione e farmacologia di nuovi composti organometallici nel trattamento del carcinoma del colon-retto. 132
Antitumor effects of carnertinib in castration resistant prostate cancer models: A Comparative study with erlotinib. 132
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 132
First-line carboplatin/nab-paclitaxel in advanced ovarian cancer patients, after hypersensitivity reaction to solvent-based taxanes: a single-institution experience 132
Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx). 131
A reflection on the actual place of osimertinib in the treatment algorithm of EGFR-positive non-small cell lung cancer patients 131
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management 131
Can malignant bowel obstruction in advanced cancer patients be treated at home ? 129
Low doses of transdermal fentanyl in opioid-naive patients with cancer pain 128
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 128
Immune Checkpoint Inhibitors and Myasthenic Syndromes: A Case Report of a Metastatic Renal Cell Carcinoma Patient Treated With Nivolumab 128
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 128
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference 128
Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: A multicenter study with external validation 128
Novel P53 mutations detected by FAMA in colorectal cancers 127
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 127
The PERSONS score: A new tool for cancer patients' symptom assessment in simultaneous care and home care settings 127
Weekly alternate intensive regimen FIrB/FOx in metastatic colorectal cancer patients: An update from clinical practice 127
Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen 127
In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human cancer cells 126
Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases 126
Cerebral metastasis from ovarian cancer treated with a multidisciplinary approach. Case report and review of literature 125
Survivorship in young women after early breast cancer: a cross-sectional study of emotional traits along 3-years perspective 125
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians’ practice 124
Timed-flat infusion (TFI) 5-fluorouracil with irinotecan and oxaliplatin in pancreatic adenocarcinomas: A single institution experience with FIr/FOx regimen 124
Multidisciplinary management of hepatocellular carcinoma in clinical practice 124
NEW MUTATIONS AND PROTEIC VARIANTS OF NBS1 ARE IDENTIFIED IN CANCER CELL LINES 123
Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy 123
Impact of primary tumor location in patients with RAS wild-type metastatic colon cancer treated with first-line chemotherapy plus anti-EGFR or anti-VEGF monoclonal antibodies: A retrospective multicenter study 122
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study 122
Sleep Disturbances in Patients with Advanced Cancer in Different Palliative Care Settings. 121
Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids 120
Biological Function of Oncogenic KRAS In Promoting Angiogenesis 120
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A “hypothesis-generator” preliminary report 120
Palliative radiotherapy in advanced cancer patients treated with immune‑checkpoint inhibitors: The PRACTICE study 120
Totale 14.461
Salva come PNG Salva come JPEG
Categoria #
all - tutte 121.676
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.676
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022938 0 0 0 68 62 24 26 91 85 33 105 444
2022/20234.568 315 300 71 492 444 471 4 298 1.943 21 125 84
2023/20241.080 151 56 49 126 75 297 11 97 2 46 35 135
2024/20254.726 120 87 434 222 641 410 616 349 1.057 219 335 236
2025/20268.755 426 926 686 1.124 904 706 1.463 313 748 912 449 98
2026/20271.543 206 266 660 411 0 0 0 0 0 0 0 0
Totale 28.334